SCHEMBL791244

SCHEMBL791244

CC(=O)N[C@@H]1[C@@H](OC(C)C)[C@H](O)[C@@H](CO)O[C@@H]1O

nearest known ligand 0.79

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPK1 P28482 2/20 0.79
▸ NOD2 Q9HC29 1/20 0.55
▸ ALDH1A1 P00352 2/20 0.54
▸ THRB P10828 1/20 0.54
▸ SMN1; SMN2 Q16637 1/20 0.43
▸ LGALS3 P17931 2/20 0.42
▸ KDM4E B2RXH2 1/20 0.42
▸ LMNA P02545 1/20 0.42
▸ CYP2D6 P10635 1/20 0.42
▸ CYP2C19 P33261 1/20 0.42
▸ CD69 Q07108 1/20 0.41
▸ ESR1 P03372 1/20 0.41
▸ PGR P06401 1/20 0.41
▸ HTR1A P08908 1/20 0.41
▸ ADORA3 P0DMS8 1/20 0.41
▸ AR P10275 1/20 0.41
▸ CHRM1 P11229 1/20 0.41
▸ TBXA2R P21731 1/20 0.41
▸ PTGS1 P23219 1/20 0.41
▸ ADRA1A P35348 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL61395 0.89 MAPK1 (0.75) MAPK1NOD2ALDH1A1THRBSMN1; SMN2
SCHEMBL13575286 0.88 MAPK1 (1.00) MAPK1NOD2ALDH1A1THRBSMN1; SMN2
SCHEMBL57603 0.88 MAPK1 (1.00) MAPK1NOD2ALDH1A1THRBSMN1; SMN2
SCHEMBL14520991 0.88 MAPK1 (1.00) MAPK1NOD2ALDH1A1THRBSMN1; SMN2
SCHEMBL163843 0.88 MAPK1 (0.73) MAPK1NOD2ALDH1A1THRBSMN1; SMN2
SCHEMBL15504324 0.88 MAPK1 (1.00) MAPK1NOD2ALDH1A1THRBSMN1; SMN2
SCHEMBL57604 0.88 MAPK1 (1.00) MAPK1NOD2ALDH1A1THRBSMN1; SMN2
SCHEMBL6552473 0.88 MAPK1 (1.00) MAPK1NOD2ALDH1A1THRBSMN1; SMN2
SCHEMBL20516489 0.88 MAPK1 (1.00) MAPK1NOD2ALDH1A1THRBSMN1; SMN2
SCHEMBL13968092 0.88 MAPK1 (0.62) MAPK1NOD2ALDH1A1THRBSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 57 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-104711258-B Plasmid of the one kind containing benzo [ghi] functional gene that can degrade 北京师范大学 2018-07-27 — — CN claimed
CN-107988220-A A kind of plasmid containing the 4- aminoquinoline functional genes that can degrade 北京师范大学 2018-05-04 — — CN claimed
CN-104256194-B A kind of functional type is saved one's life pig milk powder creep feed 湖南百宜饲料科技有限公司 2016-07-06 — — CN claimed
CN-103215264-A Degradative plasmid containing degradative benzo [b] fluoranthene genetic information UNIV BEIJING NORMAL 2013-07-24 — — CN claimed
CN-102313725-A Preparation method of lysozyme molecular imprinting-quantum dot nanoscale fluorescent probe UNIV NANKAI 2012-01-11 — — CN claimed
CN-1840182-A Application of N-acetylmuramide glycanohydrla in treatment of AIDS LIU YONGBIN (CN) 2006-10-04 — — CN claimed
EP-3706773-A2 MATURATION OF MUCOSAL DEFENSE AND GUT/LUNG FUNCTION IN THE PRETERM INFANT Defensin Therapeutics ApS (DK) 2020-09-16 — — EP disclosed
CN-109619248-A Quickly eliminate bad breath the sugar-free hard candy piece and preparation method thereof for removing helicobacter pylori 唐婷 2019-04-16 — — CN disclosed
CN-104711258-B Plasmid of the one kind containing benzo [ghi] functional gene that can degrade 北京师范大学 2018-07-27 — — CN disclosed
CN-107988220-A A kind of plasmid containing the 4- aminoquinoline functional genes that can degrade 北京师范大学 2018-05-04 — — CN disclosed
CN-106995805-A A kind of engineering bacteriophage quick detection microorganism of lysozyme mark 海南大学 2017-08-01 — — CN disclosed
CN-106520912-A Color source primer transparent circle method for detecting lysozyme activity in daily chemical product 江苏雪豹日化有限公司 2017-03-22 — — CN disclosed
US-9500381-B2 Multiuse reactors and related methods Therapeutic Proteins International, LLC (US) 2016-11-22 — — US disclosed
CN-1818060-A Silica-gel-carrier surface macroporous chitin substrate for lysozyme affinity chromatography QINGDAO SCIENCE AND TECHNOLOGY (CN) 2006-08-16 — — CN disclosed
CN-1204259-C Production process of human lysozyme as AIDS treating medicine with plant as bioreactor GANSU YASHENG SALT CHEMICAL IN (CN) 2005-06-01 — — CN disclosed
EP-1432822-A4 METHOD FOR RECOVERING AND ANALYZING A CELLULAR COMPONENT OF CULTURED CELLS WITHOUT HAVING TO HARVEST THE CELLS FIRST EMD BIOSCIENCES INC (US) 2005-02-16 — — EP disclosed
EP-1432822-A2 METHOD FOR RECOVERING AND ANALYZING A CELLULAR COMPONENT OF CULTURED CELLS WITHOUT HAVING TO HARVEST THE CELLS FIRST EMD Biosciences, Inc. (US) 2004-06-30 — — EP disclosed
CN-1468960-A Production process of human lysozyme as AIDS treating medicine with plant as bioreactor 甘肃亚盛盐化工业集团有限责任公司 2004-01-21 — — CN disclosed
WO-2003023050-A2 METHOD FOR RECOVERING AND ANALYZING A CELLULAR COMPONENT OF CULTURED CELLS WITHOUT HAVING TO HARVEST THE CELLS FIRST EMD BIOSCIENCES, INC. (US) 2003-03-20 — — WO disclosed
US-20030054435-A1 Method for recovering and analyzing a cellular component of cultured cells without having to harvest the cells first EMD CHEMICALS, INC. 2003-03-20 — — US disclosed
Send feedback